Paul Meltzer
13Patents
5h-index
19Co-inventors
63Inventor score
Filing activity: Aug 3, 1993 → Mar 12, 2013
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5545524A | Compositions and methods for chromosome region-specific probes | Emerging Cross-Sectional Technologies | 34 | Expired |
| US7247426B2 | Classifying cancers | Chemistry; Metallurgy | 26 | Expired |
| US5658730A | Methods of human prostate cancer diagnosis | Emerging Cross-Sectional Technologies | 21 | Expired |
| US5693464A | Method for generating chromosome region-specific probes | Chemistry; Metallurgy | 7 | Expired |
| US7774143B2 | Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states | Physics | 6 | Expired |
| US6562589B1 | AIB1, a novel steroid receptor co-activator | Human Necessities | 3 | Expired |
| US7783431B2 | Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states | Physics | 2 | Active |
| US9428813B2 | DNA methylation analysis for the diagnosis, prognosis and treatment of adrenal neoplasms | Chemistry; Metallurgy | 1 | Active |
| US8065092B2 | Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states | Physics | 1 | Active |
| US8620592B2 | Methods for analyzing high dimensional data for classifying, diagnosing, prognosticating, and/or predicting diseases and other biological states | Physics | 0 | Active |
| US8263759B2 | Sets of probes and primers for the diagnosis of select cancers | Emerging Cross-Sectional Technologies | 0 | Active |
| US7655397B2 | Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7232890B2 | AIB1, a novel steroid receptor co-activator | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.